BR112022002128A2 - Métodos sintéticos aprimorados para produção de compostos de (2h-1,2,3-triazol-2-il)fenila como moduladores do receptor de orexina - Google Patents

Métodos sintéticos aprimorados para produção de compostos de (2h-1,2,3-triazol-2-il)fenila como moduladores do receptor de orexina

Info

Publication number
BR112022002128A2
BR112022002128A2 BR112022002128A BR112022002128A BR112022002128A2 BR 112022002128 A2 BR112022002128 A2 BR 112022002128A2 BR 112022002128 A BR112022002128 A BR 112022002128A BR 112022002128 A BR112022002128 A BR 112022002128A BR 112022002128 A2 BR112022002128 A2 BR 112022002128A2
Authority
BR
Brazil
Prior art keywords
triazol
producing
orexin receptor
synthetic methods
receptor modulators
Prior art date
Application number
BR112022002128A
Other languages
English (en)
Inventor
Yi Chen Cheng
Paul M Depré Dominique
Damien MEDINA Florian
Kiran Matcha
Pieter Westerduin
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR112022002128A2 publication Critical patent/BR112022002128A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/74—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/76—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/74—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/78—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28—Nitrogen atoms
    • C07D295/30—Nitrogen atoms non-acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

métodos sintéticos aprimorados para produção de compostos de (2h-1,2,3-triazol-2-il)fenila como moduladores do receptor de orexina. a presente invenção refere-se a processos para a preparação de (((3ar,6as)-5-(4,6-dimetilpirimidin-2-il)hexa-hidropirrol[3,4-c]pirrol-2(1h)-il)(2-fluoro-6-(2h-1,2,3-triazol-2-il)fenil)metanona , os quais são úteis para a fabricação comercial. o dito composto é um modulador do receptor de orexina, e pode ser útil em composições farmacêuticas e métodos para o tratamento de estados doentios, distúrbios e condições mediados pela atividade da orexina, como insônia e depressão.
BR112022002128A 2019-08-07 2020-08-06 Métodos sintéticos aprimorados para produção de compostos de (2h-1,2,3-triazol-2-il)fenila como moduladores do receptor de orexina BR112022002128A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962883857P 2019-08-07 2019-08-07
US202062971265P 2020-02-07 2020-02-07
PCT/EP2020/072192 WO2021023843A1 (en) 2019-08-07 2020-08-06 Improved synthetic methods of making (2h-1,2,3-triazol-2-yl)phenyl compounds as orexin receptor modulators

Publications (1)

Publication Number Publication Date
BR112022002128A2 true BR112022002128A2 (pt) 2022-06-07

Family

ID=72139573

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022002128A BR112022002128A2 (pt) 2019-08-07 2020-08-06 Métodos sintéticos aprimorados para produção de compostos de (2h-1,2,3-triazol-2-il)fenila como moduladores do receptor de orexina

Country Status (15)

Country Link
US (1) US20220289754A1 (pt)
EP (1) EP4010325A1 (pt)
JP (1) JP2022543286A (pt)
KR (1) KR20220044323A (pt)
CN (1) CN114555603A (pt)
AU (1) AU2020324552A1 (pt)
BR (1) BR112022002128A2 (pt)
CA (1) CA3149689A1 (pt)
CR (1) CR20220050A (pt)
EC (1) ECSP22016630A (pt)
IL (1) IL290362A (pt)
JO (1) JOP20220031A1 (pt)
MX (1) MX2022001615A (pt)
PE (1) PE20220842A1 (pt)
WO (1) WO2021023843A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826833A (en) * 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
DK2491038T3 (da) * 2009-10-23 2016-07-18 Janssen Pharmaceutica Nv Disubstituerede octahydropyrrolo [3,4-c]pyrroler som orexin receptormodulatorer
US8299117B2 (en) * 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
JP6464190B2 (ja) * 2014-04-01 2019-02-06 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 複素環化合物の線虫防除のための使用

Also Published As

Publication number Publication date
KR20220044323A (ko) 2022-04-07
JOP20220031A1 (ar) 2023-01-30
EP4010325A1 (en) 2022-06-15
CR20220050A (es) 2022-04-20
ECSP22016630A (es) 2022-04-29
WO2021023843A1 (en) 2021-02-11
PE20220842A1 (es) 2022-05-24
JP2022543286A (ja) 2022-10-11
CN114555603A (zh) 2022-05-27
CA3149689A1 (en) 2021-02-11
MX2022001615A (es) 2022-05-26
AU2020324552A1 (en) 2022-03-24
US20220289754A1 (en) 2022-09-15
IL290362A (en) 2022-04-01

Similar Documents

Publication Publication Date Title
ECSP21034253A (es) Métodos sintéticos mejorados para elaborar compuestos heterocíclicos fusionados como moduladores del receptor de orexina
MX2021013110A (es) Compuestos heterociclicos como inhibidores de la cinasa ret.
CL2019001633A1 (es) Imidazol pirrol piridina como inhibidores de la familia jak de quinasas.
EP2576549A4 (en) Bicyclic Heteroarylkinase Inhibitors and Methods of Use
BR112016000195A8 (pt) compostos heterocíclicos, composição farmacêutica, combinação, seu uso, e método para inibir uma atividade da tirosina quinase btk ou jak, egfr, alk, pdgfr, blk, bmx/etk, flt3(d835y), itk, tec, txk, e suas respectivas vias
EA201492176A1 (ru) Селективные ингибиторы pi3k дельта
MA38380A1 (fr) Inhibiteurs quinazoline de l'activation des formes mutantes du récepteur de croissance épidermique (egfr)
ECSP10010263A (es) 4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpirimidin-2-aminas como inhibidores de cinasas janus
ECSP12011908A (es) OCTAHIDROPIRROLO[3,4-c]PIRROLOS DISUSTITUIDOS COMO
JO3368B1 (ar) مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
BRPI0511616A (pt) compostos
NZ630721A (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
WO2012034055A3 (en) Compounds as c-met kinase inhibitors
WO2010068483A3 (en) Mlk inhibitors and methods of use
BR112019001768A2 (pt) moduladores do receptor de spiro-lactamas nmda e usos dos mesmos
BR112017001726A2 (pt) compostos de 6,7-di-hidropirazolo [1,5-a]pirazin-4(5h)-ona e seus usos como moduladores alostéricos negativos de receptores mglur2
NZ596213A (en) 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adenosine 5'-diphosphate (ADP) receptor antagonists
BR112012028445A2 (pt) compostos de heteroarila bicíclica como moduladores de gpr119
PH12017500170A1 (en) 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
NZ744982A (en) Therapeutic compounds
MX2017001453A (es) Compuestos de 6,7-dihidropirazolo[1,5-a]pirazin-4(5h)-ona y su uso como moduladores alostericos negativos de receptores de glutamato metabotropico subtipo 2 (mglur2).
PH12016502572A1 (en) Substituted chromene derivatives as selective dual inhibitors of pi3 delta and gamma protein kinases
BR112022002128A2 (pt) Métodos sintéticos aprimorados para produção de compostos de (2h-1,2,3-triazol-2-il)fenila como moduladores do receptor de orexina
MX2022011310A (es) Azabiciclo y derivados de diazepina para tratar trastornos oculares.
MA43158B1 (fr) Composés oxa-diazadispiro possédant une activité contre la douleur